The Ethics of Medicine and Science to Be Explored at Kelly Lecture Series at Duquesne University

Duquesne’s Center for Healthcare Ethics will host a former senior advisor for bioethics at the National Institutes of Health to discuss the ethics of medicine and science as part of the David F. Kelly Bioethics Lectures.

Dr. F. Daniel Davis, professor and director of bioethics at the Geisinger Health System in Bethesda, Md., will present Integrating Bioethics: Challenges and Opportunities on Thursday, Nov. 10, from 1 to 3 p.m. in Room 613 of the Student Union. It is free and open to the public.

Davis previously served as senior advisor for bioethics and policy with the National Institutes of Health’s (NIH) Office of Science Policy in Bethesda, Md. Before taking up his post at the NIH, he served as executive director of the President’s Council on Bioethics. He is a philosopher with interests, experience and expertise in the ethics and epistemology of medicine and science.

“Today healthcare organizations need bioethics, not only for their patients and professionals but even more for themselves as responsible and compassionate agents to improve America’s health,” said Dr. Henk ten Have, director of Duquesne’s Center for Healthcare Ethics.

The David F. Kelly Bioethics Lectures invites nationally and internationally prominent scholars to lecture at Duquesne University each fall and spring semester on current and emerging topics in bioethics. The purpose of the series is to provide ethics leadership on the crucial issues in health care today.

For more information, contact Glory Smith at 412.396.4504 or visit

Duquesne University

Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.